See more : Bombay Super Hybrid Seeds Limited (BSHSL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of U-Neuron Biomedical Inc (6973.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of U-Neuron Biomedical Inc, a leading company in the None industry within the None sector.
You may be interested
- EIH Limited (EIHOTEL.NS) Income Statement Analysis – Financial Results
- Man Zai Industrial Co., Ltd. (4543.TWO) Income Statement Analysis – Financial Results
- Sanlam Limited (SLM.JO) Income Statement Analysis – Financial Results
- FinTech Acquisition Corp. VI (FTVIU) Income Statement Analysis – Financial Results
- coly Inc. (4175.T) Income Statement Analysis – Financial Results
U-Neuron Biomedical Inc (6973.TWO)
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 27.02M | 26.79M | 28.42M |
| Cost of Revenue | 5.46M | 5.21M | 4.49M |
| Gross Profit | 21.56M | 21.58M | 23.93M |
| Gross Profit Ratio | 79.78% | 80.56% | 84.21% |
| Research & Development | 76.19M | 46.77M | 26.48M |
| General & Administrative | 26.09M | 12.76M | 7.78M |
| Selling & Marketing | 8.48M | 5.72M | 4.74M |
| SG&A | 34.57M | 18.49M | 12.52M |
| Other Expenses | -90.32M | -1.15M | 3.13M |
| Operating Expenses | 21.56M | 65.26M | 39.00M |
| Cost & Expenses | 117.34M | 70.47M | 43.48M |
| Interest Income | 5.36M | 1.76M | 676.00K |
| Interest Expense | 55.00K | 109.00K | 0.00 |
| Depreciation & Amortization | 6.96M | 6.53M | 1.64M |
| EBITDA | -77.87M | -36.53M | -9.62M |
| EBITDA Ratio | -288.17% | -136.35% | -33.84% |
| Operating Income | -84.84M | -43.06M | -11.26M |
| Operating Income Ratio | -313.94% | -160.75% | -39.62% |
| Total Other Income/Expenses | -55.00K | 505.00K | 0.00 |
| Income Before Tax | -84.89M | -43.17M | -11.26M |
| Income Before Tax Ratio | -314.14% | -161.15% | -39.62% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 |
| Net Income | -84.89M | -43.17M | -11.26M |
| Net Income Ratio | -314.14% | -161.15% | -39.62% |
| EPS | -3.21 | -2.88 | -0.99 |
| EPS Diluted | -3.21 | -2.88 | -0.99 |
| Weighted Avg Shares Out | 26.46M | 15.00M | 11.37M |
| Weighted Avg Shares Out (Dil) | 26.46M | 15.00M | 11.37M |
No news found for: 6973.TWO
Source: https://incomestatements.info
Category: Stock Reports